1. Genetic polymorphisms in il-10 promoter are associated with smoking and prostate cancer risk in African Americans;Abbas;Anticancer Res.,2020
2. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results of cohort 6 of the COSMIC-021 study;Agarwal;J. Clin. Oncol.,2020
3. Immune checkpoint inhibitors of PD-L1 as cancer therapeutics;Akinleye;J. Hematol. Oncol.,2019
4. Pathological and Biochemical Outcomes amongAfrican-American and Caucasian Men with Low Risk ProstateCancer in the SEARCH Database- Implications for ActiveSurveillance Candidacy.pdf>;Anon,2016
5. Comparative genomics reveals distinct immune-oncologic pathways in african american men with prostate Cancer;Awasthi;Clin. Cancer Res.,2020